 |
-
Medical Devices: Keay Nakae
-
US-Listed Chinese Stocks: Tian Hou
-
Modern Defense: James McIlree
-
Oncology Companies: Katherine Kim
-
Application Software: Devang Kothari
-
Communication Equipment: Richard Church
-
Pulmonary Arterial Hypertension: Andrew Fein
CEO Interviews (average 2,500 words): Top management from 36 firms examine the outlook for their firm and sector. Firms interviewed include: Acusphere, Analex Corp., Anesiva, Art Technology Group, Barrier Therapeutics, BioCryst Pharmaceuticals, Captaris, CEVA, Collagenex Pharmaceuticals, Comtech Group, Corcept Therapeutics, Depomed, DIRT MotorSports, ECtel, Encysive Pharmaceuticals, Endocare, GTC Biotherapeutics, Hana Biosciences, Indus International, Insmed Inc., ISTA Pharmaceuticals, Linktone Ltd., Manhattan Pharmaceuticals, OSI Geospatial, Programmer's Paradise, QuickLogic Corp., Regeneration Technologies, Seattle Genetics, Simtek Corp., Sirna Therapeutics, Stinger Systems, Sunesis Pharmaceuticals, SYS, Syntax Brillian Corp., Ultralife Batteries, YM Biosciences and Zix Corporation.
Topics covered: Medical device companies - FDA drug approval trends - Business investment in China - Online gaming - National Security Agency spending - PDUFA dates - Software demand - Enterprise software security - IP end-to-end and IMS architectures - Consolidation in communications equipment - Therapeutic options in pulmonary hypertension
Companies covered: Johnson & Johnson (JNJ), Boston Scientific (BSX), MedicalCV (MCVI), RITA Medical (RITA), Regeneration Technologies (RTIX), Medtronic (MDT), Sohu.com (SOHU), TOM Online (TOMO), NetEase.com (NTES), Essex (KEYW), OSI Geospatial (OSI:TSX), Array BioPharma (ARRY), YM BioSciences (YMI), Hana Biosciences (HNAB), Websense (WBSN), Orpak, NICE Systems (NICE), Indus International (IINT), Verizon (VZ), ECI Telecom (ECIL), Smith Micro (SMSI), Myogen (MYOG), United Therapeutics (UTHR) and Metabasis (MBRX).
This Issue
costs $175 - and is non-returnable.
The Wall Street Transcript
does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call
(212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |